During the week of Oct. 29 - Nov. 4, the Food and Drug Administration modified the following existing Import Alerts (not otherwise listed on the FDA's new and revised import alerts page) on the detention without physical examination and/or surveillance of:
On Nov. 2 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Nov. 1 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:
The Food and Drug Administration issued its weekly Enforcement Report for Oct. 31 that lists the status of recalls and field corrections for food, drugs, biologics, and devices. The report covers both domestic and foreign firms.
On Oct. 31 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:
FDA plans for third-party certification, which serves as a key component of the Voluntary Qualified Importer Program, faces numerous challenges, the Government Accountability Office said in a report released Oct. 31. The report, “FDA Can Better Oversee Food Imports by Assessing and Leveraging Other Countries’ Oversight Resources,” recommended instead adapting FDA’s comparability assessment tool, currently in development, to determine whether exported food products are safe for domestic consumption. FDA disagreed with GAO’s conclusions.
The Food and Drug Administration (FDA) threatened to place Polish fish processor Superfish S.A.’s marinated (pickled) and salted herring products on import alert for inadequate Seafood Hazard Analysis and Critical Control Points (HACCP) plans, it said in a warning letter dated Oct. 16. Various stages of Superfish’s production process do not include critical control points, critical limits, monitoring procedures, and corrective action plans, FDA said. FDA told the company to respond within 15 days or receipt of the warning letter with actions taken to correct the deficiencies. Superfish’s products may be subject to refusal of admission into the U.S. if Superfish fails to respond adequately, FDA said.
On Oct. 29 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Oct. 26-28 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Oct. 25 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of: